Carcinomatosis treatment cost in Israel typically involves specialized diagnostics like a histopathology revision which runs $500 to $800 and primary surgical interventions. A major procedure such as Hyperthermic Intraperitoneal Chemotherapy (HIPEC) ranges from $42,000 to $68,000. Total expenses depend on the clinical stage, length of hospitalization, and the hospital's public or private status. Patients often save between 30% and 80% compared to healthcare costs in the United States. Tel Aviv and Jerusalem are the primary medical hubs for these oncology services.
Typical Carcinomatosis Treatment Costs in Israel
Bookimed Expert Insight: For patients with digestive system cancers, specialized expertise in systemic and surgical treatments is vital. Sourasky Medical Center (Ichilov) features leading experts like Dr. Pelles Sharon, who trained at the Royal Marsden for gastrointestinal oncology. Patients seeking personalized care may prefer Assuta Medical Center, where they can personally select their attending physician. Sourasky reports a 90% oncology treatment success rate, offering high-value multidisciplinary care for over 400,000 annual patients.
| Israel | Turkey | Austria | |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | from $42,000 | from $25,000 | from $40,000 |
Dr. Pelles Sharon specializes in advanced cancer treatments, including HIPEC for carcinomatosis, at Sourasky Medical Center.
Professor Ofer Merimsky brings over _doctor_28_years_ of oncology experience, specializing in sarcoma and bone tumors at Sourasky Medical Center.
Dr. Ari Raphael leads oncology trials and genomic research at Sourasky Medical Center, specializing in lung and breast cancer.
Heads the Colorectal Surgery Department at Sourasky Medical Center. He is a top specialist with over _doctor_234_years_ of experience.